Quaker Chemical (KWR) director exercises options, covers tax with shares

Rhea-AI Filing Summary

Quaker Chemical director Michael F. Barry reported stock option and related share transactions. On February 10, 2026, he exercised 8,212 employee stock options at an exercise price of $136.64 per share, receiving the same number of common shares.

On the same date, 6,876 common shares were disposed of at $176.06 per share to cover the exercise price or tax obligations, a non‑open‑market transaction coded "F." After these transactions, Barry directly owned 78,010 shares of Quaker Chemical common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BARRY MICHAEL F

(Last) (First) (Middle)

8001 TWIN EAGLES LOOP

(Street)

REUNION FL 34747

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QUAKER CHEMICAL CORP [ KWR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/10/2026		M		8,212	A	$136.64	84,886	D
Common Stock	02/10/2026		F		6,876	D	$176.06	78,010	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$136.64	02/10/2026		M			8,212	(1)	03/30/2027	Common Stock	8,212	$0	0	D

Explanation of Responses:

1. The options for this grant vested in three annual installments: 8,213 shares on March 30, 2021; 8,213 shares on March 30, 2022; and 8,212 shares on March 30, 2023.

Remarks:

	Victoria K. Gehris, Attorney-in-Fact for Michael F. Barry	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did KWR director Michael F. Barry report?

Michael F. Barry reported exercising 8,212 Quaker Chemical (KWR) stock options and receiving the same number of common shares. He also had 6,876 shares withheld in a coded "F" transaction to cover the exercise price or tax obligations, leaving 78,010 shares owned directly.

How many Quaker Chemical (KWR) shares does Michael F. Barry now own?

Following the reported transactions, Michael F. Barry directly owns 78,010 shares of Quaker Chemical common stock. This figure reflects exercising 8,212 stock options and the disposition of 6,876 shares to satisfy exercise price or tax-related obligations in a non-open-market transaction.

What do the Form 4 transaction codes M and F mean for KWR?

For Quaker Chemical (KWR), code "M" shows Michael F. Barry exercised 8,212 employee stock options at $136.64, converting them into common shares. Code "F" indicates 6,876 shares were delivered to cover the exercise price or tax liability, rather than sold in the open market.

At what prices did the KWR insider option exercise and share withholding occur?

Michael F. Barry exercised 8,212 Quaker Chemical (KWR) stock options at an exercise price of $136.64 per share. To cover related costs, 6,876 common shares were disposed of at a reported price of $176.06 per share in a tax or exercise-price withholding transaction.

What vesting schedule applied to Michael F. Barry’s KWR stock options?

The reported Quaker Chemical (KWR) stock option grant vested annually in three tranches: 8,213 shares on March 30, 2021; 8,213 shares on March 30, 2022; and 8,212 shares on March 30, 2023. The 2026 transaction reflects the exercise of the final vested portion.